News
Keeping you up to date with the clinical research sector innovations and news
Industry news
- Regeneron Announces Positive Results from Phase 3 Trial of Cemdisiran in Generalized Myasthenia Gravis
- Lilly's Oral GLP-1, Orforglipron, is Successful in Third Phase 3 Trial, Triggering Global Regulatory Submissions This Year for the Treatment of Obesity
- Rusfertide Receives Breakthrough Therapy Designation for Treatment of Erythrocytosis in Patients with Polycythemia Vera
- Valneva Announces FDA’s Decision to Suspend License of Chikungunya Vaccine Ixchiq In the U.S.
- Viking Therapeutics Announces Positive Top-Line Results from Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity
- Altimmune Announces FDA Fast Track Designation for Pemvidutide in Alcohol Use Disorder (AUD)
- Wearable technology to be offered to thousands with type 1 diabetes in UK
- NHS expands home-testing kits to detect bowel cancer earlier
- Novo Nordisk Foundation establishes new vaccine initiative worth $260m
- Key Parkinson’s protein could offer new potential targets for treatment
- BioMed X and Ono Pharmaceutical enter joint cancer research project
- Heart vests to identify those at high risk of sudden cardiac death
- Digital health collaboration to trial AI-powered X-rays for lung cancer detection
- Cognitive decline in early Alzheimer’s could stem from serotonin loss
- New filtering system to combat spread of infections in hospitals
- AstriVax awarded €3m to develop therapeutic vaccine for hepatitis B
- Sano Genetics launches ‘Light the Way’ programme for MND
- PharmaKure and UiTM enter research partnership for Alzheimer’s disease
- Study confirms safety of new flow-diverting stent to treat brain aneurysms
- ACSR to use digitised pathology for HIV-associated malignancies
- New study finds heathy cells ‘push’ cancer cells to resist treatment
- Babies born early have an increased risk of developmental disorders
- UKHSA urges individuals from ethnic minority groups to get vaccinated
- NHS rolls out online GP registration to over 2,000 practices
- Cambridge researchers redesign future mRNA therapeutics
- BioMed X launches call for applications in autoimmune disease research
Tailored Clinical Research Solutions
Holborn Gate,
330 High Holborn
London
WC1V 7QH
